Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasites.

Authors: Aguiar AC,Santos Rde M,Figueiredo FJ,Cortopassi WA,Pimentel AS,França TC,Meneghetti MR,Krettli AU,
Address: Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.
Journal: PLoS One.


Publication: 2012;7(5):e37259. doi: 10.1371/journal.pone.0037259. Epub 2012 May 23.
Free Text: Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasites.

abstract

chloroquine (CQ) is a cost effective Antimalarial drug with a relatively good safety profile (or therapeutic index). However, CQ is no longer used alone to treat patients with Plasmodium falciparum due to the emergence and spread of CQ-resistant strains, also reported for P. vivax. Despite CQ resistance, novel drug candidates based on the structure of CQ continue to be considered, as in the present work. One CQ analog was synthesized as monoquinoline (MAQ) and compared with a previously synthesized bisquinoline (BAQ), both tested against P. falciparum in vitro and against P. berghei in mice, then evaluated in vitro for their cytotoxicity and ability to inhibit hemozoin formation. Their interactions with residues present in the NADH binding site of P falciparum lactate dehydrogenase were evaluated using docking analysis software. Both compounds were active in the nanomolar range evaluated through the HRPII and hypoxanthine tests. MAQ and BAQ derivatives were not toxic, and both compounds significantly inhibited hemozoin formation, in a dose-dependent manner. MAQ had a higher selectivity index than BAQ and both compounds were weak PfLDH inhibitors, a result previously reported also for CQ. Taken together, the two CQ analogues represent promising molecules which seem to act in a crucial point for the parasite, inhibiting hemozoin formation.



Related Articles
Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
Antimicrob Agents Chemother. 2012
Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
Sáenz FE, Mutka T, Udenze K, Oduola AM, Kyle DE. Antimicrob Agents Chemother. 2012 Sep; 56(9):4685-92. Epub 2012 Jun 18.
Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.
PLoS One. 2011
Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.
Penna-Coutinho J, Cortopassi WA, Oliveira AA, França TC, Krettli AU. PLoS One. 2011; 6(7):e21237. Epub 2011 Jul 14.
Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
Biochem Pharmacol. 2007
Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
Warhurst DC, Craig JC, Adagu IS, Guy RK, Madrid PB, Fivelman QL. Biochem Pharmacol. 2007 Jun 15; 73(12):1910-26. Epub 2007 Mar 19.
Review Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Life Sci. 2007
Review Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Kumar S, Guha M, Choubey V, Maity P, Bandyopadhyay U. Life Sci. 2007 Feb 6; 80(9):813-28. Epub 2006 Nov 10.
Review The antimalarial ferroquine: from bench to clinic.
Parasite. 2011
Review The antimalarial ferroquine: from bench to clinic.
Biot C, Nosten F, Fraisse L, Ter-Minassian D, Khalife J, Dive D. Parasite. 2011 Aug; 18(3):207-14.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.